JP2023071181A5 - - Google Patents

Download PDF

Info

Publication number
JP2023071181A5
JP2023071181A5 JP2022195986A JP2022195986A JP2023071181A5 JP 2023071181 A5 JP2023071181 A5 JP 2023071181A5 JP 2022195986 A JP2022195986 A JP 2022195986A JP 2022195986 A JP2022195986 A JP 2022195986A JP 2023071181 A5 JP2023071181 A5 JP 2023071181A5
Authority
JP
Japan
Prior art keywords
methylsulfonamido
benzamide
methoxyethyl
phenyl
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022195986A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023071181A (ja
Filing date
Publication date
Priority claimed from PCT/US2018/028939 external-priority patent/WO2018200411A1/en
Application filed filed Critical
Publication of JP2023071181A publication Critical patent/JP2023071181A/ja
Publication of JP2023071181A5 publication Critical patent/JP2023071181A5/ja
Pending legal-status Critical Current

Links

JP2022195986A 2017-04-24 2022-12-07 軟骨形成を誘導するための方法 Pending JP2023071181A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762489397P 2017-04-24 2017-04-24
US62/489,397 2017-04-24
PCT/US2018/028939 WO2018200411A1 (en) 2017-04-24 2018-04-23 Methods for inducing chondrogenesis
JP2019555835A JP2020517597A (ja) 2017-04-24 2018-04-23 軟骨形成を誘導するための方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019555835A Division JP2020517597A (ja) 2017-04-24 2018-04-23 軟骨形成を誘導するための方法

Publications (2)

Publication Number Publication Date
JP2023071181A JP2023071181A (ja) 2023-05-22
JP2023071181A5 true JP2023071181A5 (https=) 2023-05-29

Family

ID=63919101

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019555835A Pending JP2020517597A (ja) 2017-04-24 2018-04-23 軟骨形成を誘導するための方法
JP2022195986A Pending JP2023071181A (ja) 2017-04-24 2022-12-07 軟骨形成を誘導するための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019555835A Pending JP2020517597A (ja) 2017-04-24 2018-04-23 軟骨形成を誘導するための方法

Country Status (10)

Country Link
US (1) US20210361600A1 (https=)
EP (1) EP3615021A4 (https=)
JP (2) JP2020517597A (https=)
KR (1) KR20190137904A (https=)
CN (1) CN110809468A (https=)
AU (1) AU2018257769A1 (https=)
CA (1) CA3060518A1 (https=)
MA (1) MA48479A (https=)
RU (1) RU2019136884A (https=)
WO (1) WO2018200411A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12186307B2 (en) 2019-02-13 2025-01-07 Yale University Methods of treating epilepsy
FI129515B (en) 2020-11-06 2022-03-31 Salarusta Oy FOR USE IN THE PREVENTION AND / OR TREATMENT OF A DISEASE OR CONDITION RELATED TO THE DEGRADATION AND / OR DISTURBANCE OF THE DEGREE OF MONTOOSASE AND / OR INTEGRITY

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9464065B2 (en) * 2011-03-24 2016-10-11 The Scripps Research Institute Compounds and methods for inducing chondrogenesis
HK1224172A1 (zh) * 2013-03-15 2017-08-18 加州生物医学研究所 用於诱导软骨形成的化合物和方法
DK3143026T3 (da) * 2014-05-13 2024-09-30 Novartis Ag Forbindelser og sammensætninger til induktion af chondrogenese

Similar Documents

Publication Publication Date Title
JP2023071181A5 (https=)
JP5586896B2 (ja) 最終分化を誘導する方法
US7148257B2 (en) Methods of treating mesothelioma with suberoylanilide hydroxamic acid
JP4077320B2 (ja) 5−メチル−1−フェニル−2−(1h)−ピリドンを有効成分として含有する医薬製剤
HRP20250148T1 (hr) Specifični triptamini za uporabu u liječenju poremećaja raspoloženja
JP2009514874A5 (https=)
JP2024075655A5 (ja) 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用
JP2004525179A5 (https=)
JP2021504384A5 (https=)
JP2015522630A5 (https=)
CY1105648T1 (el) Filbanserin για την θεραπεια εξτραπυραμιδικων διαταραχων κινησης
JP2009500443A5 (https=)
JP2006508953A5 (https=)
JP2021152008A5 (https=)
JP2022534510A5 (https=)
JP2023510332A5 (https=)
JP2024512425A5 (https=)
JP2020533296A5 (https=)
JP2018512451A5 (https=)
Paccaly et al. Absence of clinically relevant drug interaction between delamanid, a new drug for multidrug-resistant tuberculosis (MDR-TB) and tenofovir or lopinavir/ritonavir in healthy subjects
JP2005512946A5 (https=)
JP2013536206A5 (https=)
JP2020530447A5 (https=)
JP2008540405A5 (https=)
JP2020517597A5 (https=)